SEC Form 4 · accession 0000899243-15-003595
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A Sirgo
Officer — President and CEO · Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 19, 2015 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 18, 2015 | M | 20,000 | $2.94 | A | 1,086,639 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options | $2.94 | Aug 18, 2015 | M | 20,000 | D | Aug 20, 2005 | Aug 20, 2015 | Common Stock | 20,000 | 0 | D |
Explanation of responses
- F1The shares of common stock reported on this Form 4 were acquired by the Reporting Person in an exercise of options under the Registrants Amended and Restated 2001 Incentive Plan. The Reporting Person has no current intention to sell these shares of common stock resulting from the exercise of the options.